Finance
Biomedical testing company closes $15 million placement with private investors
Published in Blood Weekly, November 24th, 2005
Verax will use the funds to complete development and begin commercialization of its first product, the Platelet PGD test, a rapid test for specific detection of bacterial contamination of platelets immediately prior to transfusion.
KB Partners led the series B financing and was joined by new investors CNF Investments, SightLine Partners, Teknoinvest, and Long River Ventures as well as existing investor BioVentures Investors. Adams Harkness acted as the exclusive placement agent and financial advisor to Verax.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-11-24)
More Articles from Blood Weekly
- Blood Safety
Study shows ligand technology effective in removing blood-borne TSE infectivity - Diagnostics
Blood bank safety advanced with U.S. launch of hepatitis test - Stem Cell Transplantation
Increased TNF levels associated with increased risk of CMV infection after AHSCT - Stem Cell Transplantation
Protein C levels during HSCT conditioning do not predict veno-occlusive disease - Adverse Drug Reaction
Patients develop acute liver failure after receiving amoxicillin/clavulanate - Allergy & Immunology
Donor HLA alleles may control hepatitis C virus spread to liver grafts - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
